Stocks and Investing
Stocks and Investing
Mon, July 8, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Michael Petusky Maintained (XRAY) at Buy and Held Target at $38 on, Jul 8th, 2024
Michael Petusky of Barrington Research, Maintained "DENTSPLY SIRONA Inc." (XRAY) at Buy and Held Target at $38 on, Jul 8th, 2024.
Michael has made no other calls on XRAY in the last 4 months.
There are 5 other peers that have a rating on XRAY. Out of the 5 peers that are also analyzing XRAY, 3 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $30 on, Monday, May 6th, 2024
- Jason Bednar of "Piper Sandler" Reiterated at Hold with Decreased Target to $32 on, Friday, May 3rd, 2024
- Jeffrey Johnson of "Baird" Maintained at Hold with Decreased Target to $33 on, Friday, May 3rd, 2024
These are the ratings of the 2 analyists that currently disagree with Michael
- Elizabeth Anderson of "Evercore ISI Group" Maintained at Buy with Decreased Target to $28 on, Tuesday, June 25th, 2024
- David Saxon of "Needham" Maintained at Strong Buy with Decreased Target to $36 on, Friday, May 3rd, 2024
Contributing Sources